Management team

Mohamad Takwa, PhD

Chief Executive Officer

E-mail

An entrepreneur and strategic visionary with a decade’s experience in founding and leading innovative ventures. Extensive scientific and academic background with a PhD in Biotechnology. Loves the challenge of transforming scientific discoveries into commercial products and building innovation. Has successfully founded and led and exited ventures, including two M&As and two listings on the Swedish exchange market. Co-founded Epigenica together with Simon.

Karin Agerman, PhD

Chief Operations Officer

E-mail

A strategic leader with a proven track record of operational excellence in the pharmaceutical industry and beyond. Holds a PhD in Molecular Neurobiology and an Executive MBA, bringing deep experience in drug discovery and technology licensing. Has managed teams and projects within Multiple Sclerosis, pain, epilepsy, Alzheimer’s disease, and gene therapy.

Henk Mouthaan

Chief Commercial Officer

E-mail

A life sciences expert with a degree in Medical Biology from the University of Leiden. Brings extensive experience in multi-omics, biomarker discovery, and diagnostics, gained through senior commercial roles at Thermo Fisher Scientific and Olink Proteomics. Through a focus on bridging science and business, he has played a key role in bringing advanced technologies to market and building strong partnerships across the life science and healthcare sectors.

Banushree Kumar, PhD​

Chief Technology Officer

E-mail

A scientist with a passion for deepening our understanding of genetics and epigenetics through enabling technology tools. Has a degree in biotechnology from Bangalore, India and studied molecular biology and genetics at Lund University and the European Molecular Biology Laboratory in Heidelberg. Has a PhD from Karolinska Institutet where she has contributed significantly to the development of a novel quantitative method to study chromatin dynamics.
Board of Directors

Anders Nordström, Chairman

Other current positions: Chairman of the Board at FenoMark Diagnostics, Moleculent and Offspring Biosciences AB. Partner at Colibri Ventures.

Previous positions: Executive Vice President at Pharmacia, Board Member and CFO at Phadia AB, Board Member Halo Genomics AB, VP Finance & Operations at ArthroCare International.

Simon Elsässer, PhD​

Co-founder

E-mail

An accomplished scientist and academic specializing in biochemistry and biophysics. An Associate Professor at Karolinska Institutet and has conducted research at renowned institutions such as Harvard University. Took advanced technology venture courses at The New York Academy of Sciences, showing his dedication in bringing solutions for technology gaps to a commercial scene and for a wider use. Co-founded Epigenica together with Mohamad.

Eva Walde​

Other current positions: Board Member, Co-owner and Investor at Scale Up Life Science Invest, Board Member at FrostPharma AB, Board Member at Sedana Medical.

Previous positions: Vice President Marketing at Olink Proteomics, VP Commercial Operations International Region at Thermo Fisher Scientific, Global Brand Director at Phadia AB, Strategic Development Manager at Pfizer.

Yang Shi, PhD​

Other current positions: Professor of Epigenetics at the University of Oxford

Previous positions: Professor of Cell Biology and C. H. Waddington Professor of Pediatrics at Harvard Medical School, Professor of Pediatrics at Division of Newborn Medicine at Boston Children’s Hospital, Postdoc at Princeton University.

Stina Wallmark

Other current positions: Life Sciences Investment Director at Voima Ventures

Previous positions: Digital Strategy Leader at GE Healthcare, Digital Strategy Deployment Leader at Cytiva, Investment Manager Life Sciences at Almi Invest

Allan Asp

Other current positions: Representatve Almi Invest

Previous positions: Investment Manager at Almi Invest, senior roles in Swedish pharma and biotech including Kabi Biopharma, Pharmacia Biotech, Pyrosequencing, and Alphahelix.

This website uses cookies. By continuing to use this site, you accept our use of cookies.